JNK2 antibody (AA 130-387)
Quick Overview for JNK2 antibody (AA 130-387) (ABIN7622553)
Target
See all JNK2 (MAPK9) AntibodiesReactivity
Host
Clonality
Conjugate
Application
-
-
Binding Specificity
- AA 130-387
-
Purpose
- Mitogen Activated Protein Kinase 9 (MAPK9) Polyclonal Antibody
-
Sequence
- Tyr130~Pro387
-
Characteristics
- The Mitogen Activated Protein Kinase 9 (MAPK9) Polyclonal Antibody (Species: Human) has been validated for the following applications: WB, IHC, ICC, IP.
-
Purification
- Antigen-specific affinity chromatography followed by Protein A affinity chromatography
-
-
-
-
Application Notes
- Optimal working dilution should be determined by the investigator.
-
Restrictions
- For Research Use only
-
-
-
Format
- Liquid
-
Concentration
- 0.5 mg/mL
-
Buffer
- 0.01M PBS, pH 7.4, containing 0.05 % Proclin-300, 50 % glycerol
-
Preservative
- ProClin
-
Precaution of Use
- This product contains ProClin: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.
-
Storage
- 4 °C,-20 °C
-
Storage Comment
- 2°C to 8°C for frequent use, -20°C for 12 months. Avoid repeated freeze/thaw cycles.
-
Expiry Date
- 12 months
-
-
- JNK2 (MAPK9) (Mitogen-Activated Protein Kinase 9 (MAPK9))
-
Alternative Name
- MAPK9
-
Gene ID
- 5601
-
UniProt
- P45984
-
Pathways
- MAPK Signaling, WNT Signaling, TLR Signaling, Fc-epsilon Receptor Signaling Pathway, Activation of Innate immune Response, Cellular Response to Molecule of Bacterial Origin, Positive Regulation of Endopeptidase Activity, Hepatitis C, Toll-Like Receptors Cascades, BCR Signaling, S100 Proteins
Target
-